Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Shares Outstanding (Weighted Average): 2023-2025

Historic Shares Outstanding (Weighted Average) for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $53.9 million.

  • Upstream Bio's Shares Outstanding (Weighted Average) rose 0.58% to $53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.9 million, marking a year-over-year increase of 0.58%. This contributed to the annual value of $53.6 million for FY2024, which is 47.48% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Shares Outstanding (Weighted Average) is $53.9 million, which was up 0.22% from $53.8 million recorded in Q2 2025.
  • Upstream Bio's Shares Outstanding (Weighted Average)'s 5-year high stood at $53.9 million during Q3 2025, with a 5-year trough of $36.3 million in Q4 2023.
  • For the 3-year period, Upstream Bio's Shares Outstanding (Weighted Average) averaged around $48.8 million, with its median value being $53.6 million (2024).
  • Data for Upstream Bio's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 47.60% (in 2025) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Shares Outstanding (Weighted Average) (Quarterly) stood at $36.3 million in 2023, then soared by 47.48% to $53.6 million in 2024, then grew by 0.58% to $53.9 million in 2025.
  • Its last three reported values are $53.9 million in Q3 2025, $53.8 million for Q2 2025, and $53.6 million during Q1 2025.